Recombinant Human TACR1 Protein，His

TACR1, or Tachykinin Receptor 1, is a G-protein coupled receptor primarily involved in mediating the effects of neuropeptides such as substance P and neurokinin A. It plays a crucial role in numerous physiological processes, including pain perception, inflammation, and smooth muscle contraction. The receptor is predominantly expressed in the central and peripheral nervous systems, implicating it in various pathological conditions such as anxiety, depression, and neurodegenerative diseases. Research into TACR1 recombinant proteins has gained significant interest due to their potential therapeutic applications. The ability to produce TACR1 in a recombinant form allows for detailed functional studies and the development of selective ligands that can modulate receptor activity. Additionally, this research facilitates the exploration of TACR1 as a target for drug discovery, aiming to design novel treatments for disorders where tachykinin signaling is dysregulated. Understanding TACR1’s structure and function at a molecular level enables scientists to identify key mechanisms of action and inform the development of strategies for clinical intervention. Overall, the study of TACR1 recombinant proteins is essential for elucidating the complexities of tachykinin signaling and advancing therapeutic approaches in neurology and pain management.